Strain conferring anti-disease properties to host and bacterial cell composition
View Patent ↗The present invention provides a novel bacterial cell composition which comprises cells of Butyrivibrio fibrisolvens having the ability to produce butyric acid, a cultured material thereof or an extract thereof, and a method for inhibiting carcinogenesis, a method for immunostimulating, a method for preventing or treating a pathogen, a method for preventing or treating an inflammatory bowel disease and a method for preventing or treating an allergic disease, which use the same.
1. An isolated Butyrivibrio fibrisolvens MDT-1 strain (FERM BP-10463) or a mutant strain thereof.
2. A bacterial cell composition comprising isolated bacterial cells of Butyrivibrio fibrisolvens MDT-1 (FERM BP-10463), or an isolated culture of Butyrivibrio fibrisolvens MDT-1 (FERM BP-10463), wherein the content of bacterial cells in the bacterial cell composition is about 0.01% of the total mass of the bacterial composition.
3. A pharmaceutical formulation, comprising the bacterial cell composition of claim 2 as an active ingredient and an ingestible carrier.
4. The pharmaceutical formulation of claim 3 , wherein the ingestible carrier is a pharmaceutically acceptable carrier.
5. The pharmaceutical formulation of claim 4 , wherein the pharmaceutically acceptable carrier is in the form of a capsule, a tablet, or a powder.
6. The pharmaceutical formulation of claim 3 , wherein the ingestible carrier is a food product.